[ad_1]
The Swedish Public Health Agency is awaiting information from the European Medicines Agency (EMA), which is investigating safety issues related to the Astra Zeneca vaccine.
The reason for the decision to pause the vaccine is that a small number of cases of a possible new side effect have been reported. Side effects have consisted of blood clots in combination with bleeding. The EMA is investigating whether the cases have a connection to the vaccine. So far, no cases have been reported in Sweden.
The Swedish Public Health Agency it has now produced information for healthcare and people who have received the Astra Zeneca vaccine in the past 14 days.
“Anyone with little or no side effects doesn’t need to do anything. Transient symptoms such as fever, fatigue, or pain at the injection site in the upper arm are common and expected and are a sign that the immune system has broken down. activated. Anyone with symptoms that may indicate serious medical leave should contact healthcare, “FHM writes in a press release.
If symptoms occur, contact 1177 Vårdguiden. If you feel very ill, contact healthcare immediately or call 112.
The symptoms to watch out for are:
► Bruising and / or punctate bleeding on the skin / mucous membranes.
► Nosebleeds that are difficult to stop.
► Swelling, redness, or pronounced tenderness in the legs or arm.
The EMA message is expected to arrive on Thursday. The Swedish Public Health Agency will then announce how vaccination work can continue.
“The temporary pause of the vaccine shows that the system of taking the greatest possible care in relation to adverse reaction reports is working,” Anders Tegnell, a state epidemiologist with the Swedish Public Health Agency, said in a press release.
